Results 141 to 150 of about 11,603 (233)

Tirofiban-induced thrombocytopenia. [PDF]

Ann Med, 2023
Wang J, Zou D.
europepmc   +1 more source

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Mortality in intracoronary versus intravenous abciximab [PDF]

, 2012
Ankur Gupta, Yash Paul Sharma
openalex   +1 more source

Thrombectomy in acute myocardial infarction: Current evidence, challenges, and emerging technologies. [PDF]

World J Clin Cases
Abdeldayem T, Memon S, Omari M, Egred M, Bawamia B, Farag M, Alkhalil M.   +6 more
europepmc   +1 more source

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients [PDF]

, 2017
Krishnaraj S. Rathod, Sotiris Antoniou, Parizad Avari, Nannan Ding, P Wright, C Knight, Arun K. Jain, Anthony Mathur, EJ Smith, Roshan Weerackody, Andrew Wragg, Daniel A. Jones   +11 more
openalex   +1 more source

Badanie CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) - podsumowanie

, 2001
Aleksandra Adamowska, Jacek Kubica
openalex   +1 more source

A Case of Successful Primary Coronary Intervention for the Total Occlusion of Left Main Stem with the Aid of Abciximab [PDF]

, 2001
Myung Ho Jeong, Young Keun Ahn, Jong Cheol Park, Byoung Hee Ahn, Kook Joo Na, Nam Ho Kim, Kun Hyung Kim, Jeong Gwan Cho, Jong Chun Park, Sang Hyung Kim, Jung Chaee Kang   +10 more
openalex   +1 more source

Pharmacological and Interventional Prevention and Treatment of Microvascular Obstruction Following Primary PCI in STEMI. [PDF]

J Cardiovasc Dev Dis
Occhipinti G, Strosio M, Rinaldi R, Ruberti A, Brugaletta S.   +4 more
europepmc   +1 more source

Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions

, 2015
Ralf E. Harskamp, Niels Hoedemaker, L. Kristin Newby, Pier Woudstra, Maik J. Grundeken, Marcel A.M. Beijk, Jan J. Piek, Jan G.P. Tijssen, Rajendra H. Mehta, Robbert J. de Winter   +9 more
openalex   +2 more sources

Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA [PDF]

, 2003
Timo Lenderink
openalex   +1 more source